GSK
GSK·NYSE
--
--(--)
--
--(--)
5.27 / 10
Netural
Analyst consensus is bearish (Sell) from Barclays, while fund‑flow scores 7.77/10 with ~50% inflow across size segments but negative trends, suggesting decent liquidity yet market pessimism.
Fund Flow Rating
Analyst RatingSell
Wall Street Opinions
Sell
Strong Buy
0%
Buy
0%
Hold
0%
Sell
100%
Strong Sell
0%
James GordonSell
Date2026-01-06
InstitutionBarclays
Times predicted1
Historical Win Rate100.0%
Is money flowing into or out of GSK?
- GSK holds a Bearish analyst rating, with 100% of experts assigning a Sell grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.27/10 (Netural).
